drugset / Trial / NCT03116191

Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

NCT03116191 ↗

Phase 2 Completed 125 enrolled Sanwa Kagaku Kenkyusho Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to demonstrate efficacy of SK-1404 against placebo for the treatment of subjects with nocturia due to nocturnal polyuria, during 4 weeks of treatment.

Timeline

Start
2017-02-23
Primary completion
2017-12-15
Completion
2017-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject LAZUVAPAGON Small molecule — —

Indications